KTTA
Pasithea Therapeutics Corp
NASDAQ: KTTA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+0.87% today
Updated 2026-04-30
Market cap
$17.21M
P/E ratio
—
P/S ratio
42.15x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$0 – $2
Volume
0.4M
Pasithea Therapeutics Corp (KTTA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $247958.00 | $53.32M | $45.18M | $26.12M | $16.06M |
| Cash & equivalents | $243650.00 | $52.97M | $33.09M | $16.33M | $6.92M |
| Current assets | $247958.00 | $53.30M | $34.08M | $16.69M | $7.37M |
| Total liabilities | $6603.00 | $1.90M | $2.68M | $2.72M | $1.28M |
| Current liabilities | $6603.00 | $447280.00 | $1.88M | $2.63M | $1.12M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $241355.00 | $51.42M | $42.50M | $23.40M | $14.78M |
| Retained earnings | $-40984.00 | $-2.21M | $-19.36M | $-35.32M | $-49.58M |
| Accounts receivable | — | — | $302132.00 | $40500.00 | — |
| Inventory | — | — | $1.00 | $-40500.00 | — |
| Goodwill | — | $0.00 | $1.26M | $1.26M | $1.26M |